ERANET JPcofuND 2 - NM - Appel à projets transnational sur les mécanismes des interventions non médicamenteuses pour les maladies neurodégénératives

Hypothalamic mechanisms of High-Calorie intervention in ALS – HiCALS

Submission summary

High-fat nutritional supplementation is the first non-pharmacological treatment recognized in clinical trials to significantly prolong the survival of a large fraction of ALS patients, in particular the fast progressors. Here we hypothesize that the efficacy of the high-fat diet is linked to central effects at hypothalamic level and is due to the correction of hypothalamic disturbances that drive hypermetabolism in ALS.

Hypermetabolism is a newly identified clinical feature of Amyotrophic Lateral Sclerosis, associated with shorter survival and thought to pre-date the motor onset of disease. Substantial hypothalamic atrophy and degeneration of hypothalamic neurons suggest that the hypermetabolic state is causally related to hypothalamic dysfunction.
We plan to verify if a high-fat diet actually acts through hypothalamic mechanisms rather than purely peripheral mechanisms, using a combination of human samples from clinical trials and experimental approaches in ALS mouse models.

We will determine if the efficacy of high-fat diet is limited by the degree of the already existing hypothalamic atrophy at the time of therapy, and if specific lipidomic profile upon high-fat diet is associated with modifications of hypothalamic neuropeptides and prolonged survival. We will use single-cell transcriptomics to define the hypothalamic circuits affected by the high-fat diet in mice, and we will use chemogenetics to suppress or mimic high-fat diet effects by activating or deactivating specific hypothalamic circuits.

Our consortium brings together chemists, bioinformaticians, clinicians, neuroimaging experts and molecular biologists to successfully address these questions.
Our ultimate goal is to establish the high-fat diet as a mechanistically understood new, safe and effective disease-modifying intervention for ALS.

Project coordination

Francesco Roselli ()

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.



Help of the ANR 1,275,477 euros
Beginning and duration of the scientific project: January 2023 - 36 Months

Useful links

Explorez notre base de projets financés



ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter